Quote:

---

Any thoughts?

---

Since current usage as of now is two doses that is what I think the figure is based on. At $324.50 per vial that would be a very low revenue after costs and a split with Chiral. It's possible that will be the cost and in countries where affordability is a major concern I would have no problem with that.